45 results
8-K
EX-99.1
NTLA
Intellia Therapeutics Inc
7 Jan 19
Results of Operations and Financial Condition
8:48am
Develop Curative CRISPR-Based Medicines Advance Our Science Be the Best Place to Make Therapies Build for Long-Term Sustainability
Overview Modular …
Building for Long-Term Sustainability Modular Platform Delivery to the liver CAPABILITIES PIPELINE PROGRESSION Multiple INDs Human POC / Pivotal Trials
PRE 14A
kfjabu lig4l
18 Apr 23
Preliminary proxy
4:16pm
424B5
k3ct7bja
1 Dec 22
Prospectus supplement for primary offering
5:09pm
424B5
m9d2 16b51oj5
26 Feb 24
Prospectus supplement for primary offering
7:04am
424B5
g8n2bww
23 Feb 24
Prospectus supplement for primary offering
5:22pm
S-3ASR
8srd843nfjrk2tjr0
24 Nov 23
Automatic shelf registration
9:30am
424B5
pbryjhf
1 Jul 21
Prospectus supplement for primary offering
4:55pm
POS AM
g7yvhjcqcdgjko7iu625
27 Feb 19
Prospectus update (post-effective amendment)
8:37am
424B5
aexfwr4
30 Nov 20
Prospectus supplement for primary offering
5:06pm
424B5
n6izn9qnl kmvp
28 Jun 21
Prospectus supplement for primary offering
4:02pm
POSASR
jbts52g
27 Feb 19
Automatic shelf registration (post-effective amendment)
7:58am
424B5
6u208sd
2 Dec 20
Prospectus supplement for primary offering
4:00pm
424B5
vrcv lm6e
4 Mar 22
Prospectus supplement for primary offering
5:03pm